NO119439B - - Google Patents
Download PDFInfo
- Publication number
- NO119439B NO119439B NO160902A NO16090265A NO119439B NO 119439 B NO119439 B NO 119439B NO 160902 A NO160902 A NO 160902A NO 16090265 A NO16090265 A NO 16090265A NO 119439 B NO119439 B NO 119439B
- Authority
- NO
- Norway
- Prior art keywords
- nitrogen
- pressure
- cyanamide
- carbide
- reaction
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 82
- 229910052757 nitrogen Inorganic materials 0.000 claims description 41
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 239000005997 Calcium carbide Substances 0.000 claims description 10
- CLZWAWBPWVRRGI-UHFFFAOYSA-N tert-butyl 2-[2-[2-[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]-5-bromophenoxy]ethoxy]-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino]acetate Chemical compound CC1=CC=C(N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)C(OCCOC=2C(=CC=C(Br)C=2)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)=C1 CLZWAWBPWVRRGI-UHFFFAOYSA-N 0.000 claims description 10
- MVXMNHYVCLMLDD-UHFFFAOYSA-N 4-methoxynaphthalene-1-carbaldehyde Chemical compound C1=CC=C2C(OC)=CC=C(C=O)C2=C1 MVXMNHYVCLMLDD-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 3
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000005121 nitriding Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 150000001912 cyanamides Chemical class 0.000 description 3
- 229910014813 CaC2 Inorganic materials 0.000 description 2
- UFONUKZQWFSQLP-UHFFFAOYSA-N [N].NC#N Chemical compound [N].NC#N UFONUKZQWFSQLP-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000006902 nitrogenation reaction Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ZIPLUEXSCPLCEI-UHFFFAOYSA-N cyanamide group Chemical group C(#N)[NH-] ZIPLUEXSCPLCEI-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- MBEGFNBBAVRKLK-UHFFFAOYSA-N sodium;iminomethylideneazanide Chemical compound [Na+].[NH-]C#N MBEGFNBBAVRKLK-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US428210A US3400197A (en) | 1965-01-26 | 1965-01-26 | Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules |
Publications (1)
Publication Number | Publication Date |
---|---|
NO119439B true NO119439B (pt) | 1970-05-19 |
Family
ID=23697978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO160902A NO119439B (pt) | 1965-01-26 | 1965-12-14 |
Country Status (11)
Country | Link |
---|---|
US (1) | US3400197A (pt) |
AT (1) | AT267068B (pt) |
BE (1) | BE675379A (pt) |
BR (1) | BR6576133D0 (pt) |
DK (1) | DK115350B (pt) |
ES (1) | ES321779A1 (pt) |
FR (2) | FR5137M (pt) |
GB (1) | GB1113860A (pt) |
IL (1) | IL24813A (pt) |
NL (1) | NL6516147A (pt) |
NO (1) | NO119439B (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2360796B2 (de) * | 1973-12-06 | 1977-06-02 | Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München | Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm |
US4013785A (en) * | 1975-03-21 | 1977-03-22 | Bristol-Myers Company | Apap tablet containing fumed silica and process for manufacturing same |
NL7510104A (nl) * | 1975-08-27 | 1977-03-01 | Akzo Nv | Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. |
DE2845326C2 (de) * | 1978-10-18 | 1985-05-23 | Beiersdorf Ag, 2000 Hamburg | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung |
JPS56500138A (pt) * | 1979-03-16 | 1981-02-12 | ||
DE3124983A1 (de) * | 1981-06-25 | 1983-01-20 | Meditest Inst Fuer Medizinisch | Arzneiformen zur oralen verabreichung |
JPS5839618A (ja) * | 1981-09-04 | 1983-03-08 | Chugai Pharmaceut Co Ltd | 持続性積層錠剤 |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
US4521402A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of hydrazine |
US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
US4522804A (en) * | 1983-01-03 | 1985-06-11 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of propranolol |
US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
AU581177B2 (en) * | 1983-05-31 | 1989-02-16 | Choong-Gook Jang | Dry direct compression compositions for controlled release dosage forms |
US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
AT385654B (de) * | 1984-09-04 | 1988-05-10 | Arcana Chem Pharm | Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung |
GB8518927D0 (en) * | 1985-07-26 | 1985-09-04 | Vincent Processes Ltd | Tablets |
GB2186485B (en) * | 1986-02-13 | 1988-09-07 | Ethical Pharma Ltd | Slow release formulation |
US4820523A (en) * | 1986-04-15 | 1989-04-11 | Warner-Lambert Company | Pharmaceutical composition |
US4795642A (en) * | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
ATE321529T1 (de) * | 1996-09-30 | 2006-04-15 | Alza Corp | Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung |
EP1690531A3 (en) * | 1996-09-30 | 2010-01-20 | Alza Corporation | Dosage form and method for administering drug |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
EP1202745A4 (en) * | 1999-08-16 | 2004-09-22 | Henceforth Hibernia Inc | THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS CONTAINING CATALYTIC BIOMIMETIC SOLIDS AND METHODS OF PREPARING AND USING SAME |
US6264983B1 (en) | 1999-09-16 | 2001-07-24 | Rhodia, Inc. | Directly compressible, ultra fine acetaminophen compositions and process for producing same |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
EP1414458B1 (en) * | 2001-07-06 | 2007-04-11 | Endo Pharmaceuticals Inc. | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
JP2006517929A (ja) * | 2003-02-19 | 2006-08-03 | ハー・ルンドベック・アクチエゼルスカベット | 溶融アグロメレーションを用いてアグロメレートを製造する方法 |
WO2004073689A1 (en) * | 2003-02-19 | 2004-09-02 | Lifecycle Pharma A/S | Use of a silica or silica derivative as a sorption material |
US9308164B2 (en) | 2004-06-30 | 2016-04-12 | Sovereign Pharmaceuticals, Llc | Hyoscyamine dosage form |
JP3955868B2 (ja) * | 2004-12-27 | 2007-08-08 | 株式会社キングジム | 書類等の綴じ具 |
BRPI0519481A2 (pt) | 2004-12-27 | 2009-02-03 | Beiersdorf Ag | glicopirrolato em preparaÇÕes cosmÉticas |
DE102005029386A1 (de) * | 2005-06-23 | 2007-01-11 | Beiersdorf Ag | Wirkstoffkombinationen aus Glycopyrroniumbromid und einem oder mehreren Hydrokolloiden |
US9005652B2 (en) * | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
DE102006046358B3 (de) * | 2006-09-28 | 2007-11-29 | Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. | Verfahren zur Herstellung von funktionellen cellulosischen Formkörpern |
AP2986A (en) | 2007-02-23 | 2014-09-30 | Gilead Sciences Inc | Modulators of pharmacokinetic properties of therapeutics |
WO2009135179A2 (en) * | 2008-05-02 | 2009-11-05 | Gilead Sciences, Inc. | The use of solid carrier particles to improve the processability of a pharmaceutical agent |
ME02874B (me) | 2010-12-22 | 2018-04-20 | Purdue Pharma Lp | Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu |
CN103327969A (zh) | 2010-12-23 | 2013-09-25 | 普渡制药公司 | 抗篡改固体口服剂型 |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2793979A (en) * | 1953-03-30 | 1957-05-28 | Smith Kline French Lab | Method of making a sustained release pharmaceutical tablet and product of the method |
US2951791A (en) * | 1959-08-31 | 1960-09-06 | American Cyanamid Co | Use of calcium silicate in tablet compressing |
US2951792A (en) * | 1959-11-18 | 1960-09-06 | Smith Kline French Lab | Sustained release pharmaceutical tablets |
NL135732A (pt) * | 1960-11-17 | |||
US3148124A (en) * | 1962-06-12 | 1964-09-08 | William E Gaunt | Method of preparing sustained release pharmaceutical tablets |
US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
-
1965
- 1965-01-26 US US428210A patent/US3400197A/en not_active Expired - Lifetime
- 1965-12-09 GB GB52366/65A patent/GB1113860A/en not_active Expired
- 1965-12-10 NL NL6516147A patent/NL6516147A/xx unknown
- 1965-12-14 NO NO160902A patent/NO119439B/no unknown
- 1965-12-16 IL IL24813A patent/IL24813A/xx unknown
- 1965-12-30 DK DK670965AA patent/DK115350B/da unknown
- 1965-12-30 BR BR176133/65A patent/BR6576133D0/pt unknown
-
1966
- 1966-01-14 ES ES0321779A patent/ES321779A1/es not_active Expired
- 1966-01-18 AT AT44566A patent/AT267068B/de active
- 1966-01-20 BE BE675379A patent/BE675379A/xx unknown
- 1966-01-26 FR FR47277A patent/FR5137M/fr not_active Expired
- 1966-01-26 FR FR47278A patent/FR1465919A/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR5137M (pt) | 1967-06-05 |
AT267068B (de) | 1968-12-10 |
BR6576133D0 (pt) | 1973-09-06 |
FR1465919A (fr) | 1967-01-13 |
BE675379A (pt) | 1966-05-31 |
GB1113860A (en) | 1968-05-15 |
ES321779A1 (es) | 1966-06-16 |
US3400197A (en) | 1968-09-03 |
IL24813A (en) | 1969-06-25 |
NL6516147A (pt) | 1966-07-27 |
DK115350B (da) | 1969-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO119439B (pt) | ||
US2568901A (en) | Process for producing ammonium nitrate | |
GB1001984A (en) | Improvements in and relating to phosphates | |
US2056283A (en) | Process for the production of urea and an ammonium salt | |
US1859998A (en) | Hydrated silica | |
NO123181B (pt) | ||
US3223145A (en) | Evaporative concentration of aqueous urea | |
SU1370073A1 (ru) | Способ получени фосфора | |
US2959463A (en) | Process for manufacture of lithium nitrate | |
US2007478A (en) | Production of nitrates from metal halides | |
US1456831A (en) | Process for the commercial preparation of potassium phosphate | |
Bhuiyan et al. | Production of Carbon-di-sulphide by reaction of by-product gypsum with Carbon tetrachloride vapour | |
SU789390A1 (ru) | Способ получени экстракционной фосфорной кислоты | |
US2036701A (en) | Production of mixed fertilizer | |
US2064978A (en) | Recovering nitrogen from nitrosyl chloride | |
US1018406A (en) | Manufacture of ammonium carbonate. | |
US394387A (en) | james simpson | |
NO120687B (pt) | ||
US1551824A (en) | Process for the production of a fertilizer containing potassium and nitrogen | |
US1966395A (en) | Process for producing calcium nitrate fertilizers | |
DE342413C (de) | Verfahren zur Bindung von atmosphaerischem Stickstoff | |
SU492499A2 (ru) | Способ изготовлени известково-песчаных изделий | |
AU637949B2 (en) | Process for obtaining crystallized sodium cyanide, free of, or containing regulable amounts of, sodium hydroxide | |
GB990966A (en) | Selective fluorination and extraction of beryllium-containing ores | |
US1003433A (en) | Process of making ammonia. |